Impact of pegylated filgrastim in comparison to filgrastim for patients with acute myeloid leukaemia (AML) on high-dose cytarabine (HIDAC) consolidation chemotherapy
Crossref DOI link: https://doi.org/10.1007/s00520-014-2417-7
Published Online: 2014-08-27
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kam, Grace
Yiu, Richard
Loh, Yvonne
Ang, Ai Leen
Yueh, Ling Ling
Goh, Yeow Tee
Wong, Gee Chuan
Text and Data Mining valid from 2014-08-27